Artemisinin attenuates doxorubicin induced cardiotoxicity and hepatotoxicity in rats

References

• Abdin MZ, Alam P. 2015. Genetic engineering of artemisinin biosynthesis: prospects to improve its production. Acta Physiol Plant. 37:33–45. doi:10.1007/s11738-015-1771-5.
   Web of Science ®Google Scholar
• Alkreathy H, Damanhouri ZA, Ahmed N, Slevin M, Ali SS, Osman AMM. 2010. Aged garlic extract protects against doxorubicin-induced cardiotoxicity in rats. Food Chem Toxicol. 48:951–956. doi:10.1016/j.fct.2010.01.005.
   PubMed Web of Science ®Google Scholar
• Attia GM, Elmansy RA, Algaidi SA. 2017. Silymarin decreases the expression of VEGF-A, iNOS and caspase-3 and preserves the ultrastructure of cardiac cells in doxorubicin induced cardiotoxicity in rats: a possible protective role. Int J Clin Exp Med. 10:4158–4173.
   Web of Science ®Google Scholar
• Balint GA. 2001. Artemisinin and its derivatives: an important new class of antimalarial agents. Pharmacol Ther. 90:261–265.
   PubMed Web of Science ®Google Scholar
• Balunas MJ, Kinghorn AD. 2005. Drug discovery from medicinal plants. Life Sci. 78:431–441. doi:10.1016/j.lfs.2005.05.067.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Karin M. 1997. Nuclear factor-κB-a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 336:1066–1071. doi:10.1056/NEJM199704103361506.
   PubMed Web of Science ®Google Scholar
• Beekman AC, Wierenga PK, Woerdenbag HJ, Van Uden W, Pras N, Konings AW, El-Feraly FS, Galal AM, Wikström HV. 1998. Artemisinin-derived sesquiterpene lactones as potential antitumour compounds: cytotoxic action against bone marrow and tumour cells. Planta Med. 64:615–619. doi:10.1055/s-2006-957533.
   PubMed Web of Science ®Google Scholar
• Bilir EK, Tutun H, Sevin S, Kismali G, Yarsan E. 2018. Cytotoxic effects of Rhododendron ponticum L. extract on prostate carcinoma and adenocarcinoma cell line (DU145, PC3). Kafkas Univ Vet Fak Derg. 24:451–457.
   Web of Science ®Google Scholar
• Cecen E, Dost T, Culhaci N, Karul A, Ergur B, Birincioglu M. 2011. Protective effects of silymarin against doxorubicin-induced toxicity. Asian Pac J Cancer Prev. 12:2697–2704.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang L, Hao M. 2018. Effect of artemisinin on proliferation and apoptosis-related protein expression in vivo and in vitro. Saud J Biol Sci. 25:1488–1493. doi:10.1016/j.sjbs.2018.04.003.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang Y, Zhu Z, Liu H, Guo H, Xiong C, Xie K, Zhang X, Su S. 2016. Protective effect of berberine on doxorubicin-induced acute hepatorenal toxicity in rats. Mol Med Rep. 13:3953–3960. doi:10.3892/mmr.2016.5017.
   PubMed Web of Science ®Google Scholar
• Cumming JN, Ploypradith P, Posner GH. 1996. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action. Adv Pharmacol. 37:253–297.
   Google Scholar
• Das AK. 2015. Anticancer effect of antimalarial artemisinin compounds. Ann Mil Health Sci Res. 5:93–102. doi:10.4103/2141-9248.153609.
   PubMed Web of Science ®Google Scholar
• Deepa PR, Varalakshmi P. 2003. Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity. Chem Biol Interact. 146:201–210.
   PubMed Web of Science ®Google Scholar
• Djabir YY, Arsyad MA, Sartini S, Lallo S. 2017. Potential roles of Kleinhovia hospita L. leaf extract in reducing doxorubicin acute hepatic, cardiac and renal toxicities in rats. Pharmacogn Res. 9:168–173.
   PubMed Web of Science ®Google Scholar
• Drăgan L, Györke A, Ferreira JF, Pop IA, Dunca I, Drăgan M, Mircean V, Dan I, Cozma V. 2014. Effects of Artemisia annua and Foeniculum vulgare on chickens highly infected with Eimeria tenella (Phylum Apicomplexa). Acta Vet Scand. 56:22–29. doi:10.1186/1751-0147-56-22.
   PubMed Web of Science ®Google Scholar
• El-Moselhy MA, El-Sheikh AA. 2014. Protective mechanisms of atorvastatin against doxorubicin-induced hepato-renal toxicity. Biomed Pharmacother. 68:101–110. doi:10.1016/j.biopha.2013.09.001.
   PubMed Web of Science ®Google Scholar
• Farombi EO, Adedara IA, Abolaji AO, Anamelechi JP, Sangodele JO. 2014. Sperm characteristics, antioxidant status and hormonal profile in rats treated with artemisinin. Andrologia. 46:893–901. doi:10.1111/and.12170.
   PubMed Web of Science ®Google Scholar
• Firestone GL, Sundar SN. 2009. Anticancer activities of artemisinin and its bioactive derivatives. Expert Rev Mol Med. 11:1–15. doi:10.1017/S1462399409001239.
   Web of Science ®Google Scholar
• Fujimura L, Matsudo Y, Kang M, Takamori Y, Tokuhisa T, Hatano M. 2004. Protective role of Nd1 in doxorubicin-induced cardiotoxicity. Cardiovasc Res. 64:315–321. doi:10.1016/j.cardiores.2004.07.009.
   PubMed Web of Science ®Google Scholar
• Galal AM, Ross SA, Jacob M, El Sohly MA. 2005. Antifungal activity of artemisinin derivatives. J Nat Prod. 68:1274–1276. doi:10.1021/np050074u.
   PubMed Web of Science ®Google Scholar
• Gorini S, De Angelis A, Berrino L, Malara N, Rosano G, Ferraro E. 2018. Chemotherapeutic drugs and mitochondrial dysfunction: focus on doxorubicin, trastuzumab, and sunitinib. Oxid Med Cell Longev. 18. doi:10.1155/2018/7582730.
   Web of Science ®Google Scholar
• Gu Y, Wang X, Wang X, Yuan M, Wu G, Hu J, Huang C. 2012. Artemisinin attenuates post-infarct myocardial remodeling by down-regulating the NF-κB pathway. Tohoku J Exp Med. 227:161–170.
   PubMed Web of Science ®Google Scholar
• Hensley K, Robinson KA, Gabbita SP. 2000. Reactive oxygen species, cell signaling, and cell injury. Free Rad Biol Med. 28:1456–1462. doi:10.1016/S0891-5849(00)00252-5.
   PubMed Web of Science ®Google Scholar
• Hiramine C. 1997. Definition and morphological features of apoptosis. Rinsho Byori. 45:459–469.
   PubMedGoogle Scholar
• Hoppe HC, van Schalkwyk DA, Wiehart UI, Meredith SA, Egan J, Weber BW. 2004. Antimalarial quinolines and artemisinin inhibit endocytosis in Plasmodium falciparum. Antimicrob Agents Chemother. 48:2370–2378. doi:10.1128/AAC.48.7.2370-2378.2004.
   PubMed Web of Science ®Google Scholar
• Hou J, Wang D, Zhang R, Wang H. 2008. Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action. Clin Cancer Res. 14:5519–5530. doi:10.1158/1078-0432.CCR-08-0197.
   PubMed Web of Science ®Google Scholar
• Hou L, Block KE, Huang H. 2014. Artesunate abolishes germinal center B cells and inhibits autoimmune arthritis. PLoS One. 9:e104762. doi:10.1371/journal.pone.0104762.
   PubMed Web of Science ®Google Scholar
• Idriss HT, Naismith JH. 2000. TNFα and the TNF receptor superfamily: structure‐function relationship(s). Microsc Res Tech. 50:184–195. doi:10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H.
   PubMed Web of Science ®Google Scholar
• Jamalzadeh L, Ghafoori H, Aghamaali M, Sariri R. 2017. Induction of apoptosis in human breast cancer mcf-7 cells by a semi-synthetic derivative of artemisinin: a caspase-related mechanism. Iran J Biotechnol. 15:157–165. doi:10.15171/ijb.1567.
   PubMed Web of Science ®Google Scholar
• Janssen-Heininger YM, Macara I, Mossman BT. 1999. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-κ b: requirement of ras/mitogen-activated protein kinases in the activation of Nf-κ B by oxidants. Am J Respir Cell Mol Biol. 20:942–952. doi:10.1165/ajrcmb.20.5.3452.
   PubMed Web of Science ®Google Scholar
• Kalender Y, Yel M, Kalender S. 2005. Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats: the effects of vitamin E and catechin. Toxicology. 209:39–45. doi:10.1016/j.tox.2004.12.003.
   PubMed Web of Science ®Google Scholar
• Kalyanaraman B, Joseph J, Kalivendi S, Wang S, Konorev E, Kotamraju S. 2002. Doxorubicin-induced apoptosis: implications in cardiotoxicity. Mol Cell Biochem. 234:119–124.
   PubMed Web of Science ®Google Scholar
• Kim WS, Choi WJ, Lee S, Kim WJ, Lee DC, Sohn UD, Shin HS, Kim W. 2015. Anti-inflammatory, antioxidant and antimicrobial effects of artemisinin extracts from Artemisia annua L. Kor. J Physiol Pharmacol. 19:21–27. doi:10.4196/kjpp.2015.19.1.21.
   Web of Science ®Google Scholar
• Kurokawa M, Kornbluth S. 2009. Caspases and kinases in a death grip. Cell. 138:838–854. doi:10.1016/j.cell.2009.08.021.
   PubMed Web of Science ®Google Scholar
• Lechner M, Lirk P, Rieder J. 2005. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Sem Cancer Biol. 15:277–289. doi:10.1016/j.semcancer.2005.04.004.
   PubMed Web of Science ®Google Scholar
• Lefrak EA, Pitha J, Rosenheim S, Gottlieb J. 1973. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer. 32:302–314.3. doi:10.1002/1097-0142(197307)32:1<266::aid-cncr2820320139>3.0.co;2-g.
   PubMed Web of Science ®Google Scholar
• Lin X, Li Q, Wang YJ, Ju YW, Chi ZQ, Wang MW, Liu JG. 2007. Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor κB transcriptional activation in neuroblastoma SH-SY5Y cells. Biochem J. 406:215–221. doi:10.1042/BJ20070186.
   PubMed Web of Science ®Google Scholar
• Lowe SW, Lin AW. 2000. Apoptosis in cancer. Carcinogenesis. 21:485–495. doi:10.1093/carcin/21.3.485.
   PubMed Web of Science ®Google Scholar
• Luna GL. 1968. Manual of histologic staining methods of the armed forces institute of pathology. 3rd ed. New York (NY): McGraw Hill Book Co.; p. 32–34.
   Google Scholar
• Mohamad RH, El-Bastawesy AM, Zekry ZK, Al-Mehdar HA, Al-Said MGAM, Aly SS, Sharawy SM, El-Merzabani MM. 2009. The role of Curcuma longa against doxorubicin (adriamycin)-induced toxicity in rats. J Med Food. 12:394–402. doi:10.1089/jmf.2007.0715.
   PubMed Web of Science ®Google Scholar
• Mostafa MG, Mima T, Ohnishi ST, Mori K. 2000. S-allylcysteine ameliorates doxorubicin toxicity in the heart and liver in mice. Planta Med. 66:148–151. doi:10.1055/s-2000-11124.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Banerjee SK, Maulik M, Dinda AK, Talwar KK, Maulik SK. 2003. Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-α expression. BMC Pharmacol. 3:16–25. doi:10.1186/1471-2210-3-16.
   PubMedGoogle Scholar
• O’Neill PM, Barton VE, Ward SA. 2010. The molecular mechanism of action of artemisinin-the debate continues. Molecules. 15:1705–1721. doi:10.3390/molecules15031705.
   PubMed Web of Science ®Google Scholar
• Pandey KB, Rizvi SI. 2009. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev. 2:270–278. doi:10.4161/oxim.2.5.9498.
   PubMed Web of Science ®Google Scholar
• Perry BC, Soltys D, Toledo AH, Toledo-Pereyra LH. 2011. Tumor necrosis factor-α in liver ischemia/reperfusion injury. J Invest Surg. 24:178–188. doi:10.3109/08941939.2011.568594.
   PubMed Web of Science ®Google Scholar
• Pointon AV, Walker TM, Phillips KM, Luo J, Riley J, Zhang SD, Parry JD, Lyon JJ, Marczylo EL, Gant TW. 2010. Doxorubicin in vivo rapidly alters expression and translation of myocardial electron transport chain genes, leads to ATP loss and caspase 3 activation. PLoS One. 5:e12733. doi:10.1371/journal.pone.0012733.
   PubMed Web of Science ®Google Scholar
• Porter AG, Jänicke RU. 1999. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. doi:10.1038/sj.cdd.4400476.
   PubMed Web of Science ®Google Scholar
• Rashid S, Ali N, Nafees S, Ahmad ST, Arjumand W, Hasan SK, Sultana S. 2013. Alleviation of doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in Wistar rats. Toxicol Mech Methods. 23:337–345. doi:10.3109/15376516.2012.759306.
   PubMed Web of Science ®Google Scholar
• Riganti C, Doublier S, Costamagna C, Aldieri E, Pescarmona G, Ghigo D, Bosia A. 2008. Activation of NF-kB pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells. Mol Pharmacol. 74:476–484. doi:10.1124/mol.108.045286.
   PubMed Web of Science ®Google Scholar
• Romero MR, Serrano MA, Vallejo M, Efferth T, Alvarez M, Marin JJ. 2006. Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV). Planta Med. 72:1169–1174. doi:10.1055/s-2006-947198.
   PubMed Web of Science ®Google Scholar
• Rudrapal M, Chetia D. 2016. Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1, 2, 4-trioxane-based structural scaffold. Drug Des Devel Ther. 10:3575–3590. doi:10.2147/DDDT.S118116.
   PubMed Web of Science ®Google Scholar
• Saad SY, Najjar TA, Al-Rikabi AC. 2001. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res. 43:211–218. doi:10.1006/phrs.2000.0769.
   PubMed Web of Science ®Google Scholar
• Saleem MT, Chetty MC, Kavimani S. 2014. Antioxidants and tumor necrosis factor alpha-inhibiting activity of sesame oil against doxorubicin-induced cardiotoxicity. Ther Adv Cardiovasc Dis. 8:4–11. doi:10.1177/1753944713516532.
   PubMedGoogle Scholar
• Shaker RA, Abboud SH, Assad HC, Hadi N. 2018. Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis. BMC Pharmacol Toxicol. 19:3–13. doi:10.1186/s40360-017-0184-z.
   PubMed Web of Science ®Google Scholar
• Shin SA, Moon S, Kim WY, Paek SM, Park H, Lee C. 2018. Structure-based classification and anti-cancer effects of plant metabolites. Int J Mol Sci. 19:2651–2684. doi:10.3390/ijms19092651.
   Web of Science ®Google Scholar
• Shivakumar P, Rani MU, Reddy AG, Anjaneyulu Y. 2012. A study on the toxic effects of doxorubicin on the histology of certain organs. Toxicol Int. 19:241–244. doi:10.4103/0971-6580.103656.
   PubMedGoogle Scholar
• Singal PK, Iliskovic N. 1998. Doxorubicin-induced cardiomyopathy. N Engl J Med. 339:900–905. doi:10.1056/NEJM199809243391307.
   PubMed Web of Science ®Google Scholar
• Singh NP, Lai HC. 2004. Artemisinin induces apoptosis in human cancer cells. Anticancer Res. 24:2277–2280.
   PubMed Web of Science ®Google Scholar
• Singh NP, Lai HC, Park JS, Gerhardt TE, Kim BJ, Wang S, Sasaki T. 2011. Effects of artemisinin dimers on rat breast cancer cells in vitro and in vivo. Anticancer Res. 31:4111–4114.
   PubMed Web of Science ®Google Scholar
• Siswanto S, Arozal W, Juniantito V, Grace A, Agustini FD. 2016. The effect of mangiferin against brain damage caused by oxidative stress and inflammation induced by doxorubicin. HAYATI J Biosci. 23:51–55. doi:10.1016/j.hjb.2016.02.001.
   Google Scholar
• Skowyra M, Gallego MG, Segovia F, Almajano MP. 2014. Antioxidant properties of Artemisia annua extracts in model food emulsions. Antioxidants. 3:116–128. doi:10.3390/antiox3010116.
   Google Scholar
• Sorensen JC, Cheregi BD, Timpani CA, Nurgali K, Hayes A, Rybalka E. 2016. Mitochondria: inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting? Cancer Chemother Pharmacol. 78:673–683. doi:10.1007/s00280-016-3045-3.
   PubMed Web of Science ®Google Scholar
• Sun LH, Li HZ, Han LP, Jiang CM, Zhao YJ, Gao XX, Tian Y, Xu CQ. 2007. Effect of artemisinin on ischemia/reperfusion injury of isolated rat myocardium. Zhongguo Zhong Yao Za Zhi. 32:1547–1551.
   PubMedGoogle Scholar
• Thannickal VJ, Fanburg BL. 2000. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol. 279:L1005–L1028. doi:10.1152/ajplung.2000.279.6.L1005.
   PubMed Web of Science ®Google Scholar
• Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP. 2008. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther. 117:244–279. doi:10.1016/j.pharmthera.2007.10.001.
   PubMed Web of Science ®Google Scholar
• Tu Y. 2016. Artemisinin-a gift from traditional Chinese medicine to the world (Nobel lecture). Angew Chem Int Ed. 55:10210–10226. doi:10.1002/anie.201601967.
   PubMed Web of Science ®Google Scholar
• Turner MD, Nedjai B, Hurst T, Pennington DJ. 2014. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta. 1843:2563–2582. doi:10.1016/j.bbamcr.2014.05.014.
   PubMed Web of Science ®Google Scholar
• Van Agtmael MA, Eggelte TA, van Boxtel CJ. 1999. Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication. Trends Pharmacol Sci. 20:199–205. doi:10.1016/S0165-6147(99)01302-4.
   PubMed Web of Science ®Google Scholar
• Wang KS, Li J, Wang Z, Mi C, Ma J, Piao LX, Xu GH, Li X, Jin X. 2017. Artemisinin inhibits inflammatory response via regulating NF-κB and MAPK signaling pathways. Immunopharmacol Immunotoxicol. 39:28–36. doi:10.1080/08923973.2016.1267744.
   PubMed Web of Science ®Google Scholar
• Warpe VS, Mali VR, Arulmozhi S, Bodhankar SL, Mahadik KR. 2015. Cardioprotective effect of ellagic acid on doxorubicin induced cardiotoxicity in Wistar rats. J Acute Med. 5:1–8. doi:10.1016/j.jacme.2015.02.003.
   Web of Science ®Google Scholar
• Weinstein DM, Mihm MJ,Bauer JA. 2000. Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. J Pharmacol Exp Ther. 294:396–401.
   PubMed Web of Science ®Google Scholar
• Wesselborg S, Engels IH, Rossmann E, Los M, Schulze-Osthoff K. 1999. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. Blood. 93:3053–3063.
   PubMed Web of Science ®Google Scholar
• Willoughby JA, Sundar SN, Cheung M, Tin AS, Modiano J, Firestone GL. 2009. Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression. J Biol Chem. 284:2203–2213. doi:10.1074/jbc.M804491200.
   PubMed Web of Science ®Google Scholar
• Yadav U, Ramana KV. 2013. Regulation of NF-B-induced inflammatory signaling by lipid peroxidation-derived aldehydes. Oxid Med Cell Longev. 2013:1–11. doi:10.1155/2013/690545.
   Web of Science ®Google Scholar
• Yagmurca M, Fadillioglu E, Erdogan H, Ucar M, Sogut S, Irmak MK. 2003. Erdosteine prevents doxorubicin-induced cardiotoxicity in rats. Pharmacol Res. 48:377–382. doi:10.1016/S1043-6618(03)00185-3.
   PubMed Web of Science ®Google Scholar
• Yeh ET, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C, Durand JB, Gibbs H, Zafarmand AA, Ewer MS. 2004. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation. 109:3122–3131. doi:10.1161/01.CIR.0000133187.74800.B9.
   PubMed Web of Science ®Google Scholar
• Yilmaz S, Atessahin A, Sahna E, Karahan I, Ozer S. 2006. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicology. 218:164–171. doi:10.1016/j.tox.2005.10.015.
   PubMed Web of Science ®Google Scholar
• Zhao X, Wang L, Zhang H, Zhang D, Zhang Z, Zhang J. 2017. Protective effect of artemisinin on chronic alcohol induced liver damage in mice. Env Toxicol Pharmacol. 52:221–226. doi:10.1016/j.etap.2017.04.008.
   PubMed Web of Science ®Google Scholar
• Zyad A, Tilaoui M, Jaafari A, Oukerrou MA, Mouse HA. 2018. More insights into the pharmacological effects of artemisinin. Phytother Res. 32:216–229. doi:10.1002/ptr.5958.
   PubMed Web of Science ®Google Scholar